| Dasatinib |
ENSG00000088970.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000104691.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000124835.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000124915.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000131484.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000132204.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000146666.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000152487.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000163597.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000167912.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000170161.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000170846.11 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000170919.11 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000172250.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000172965.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000172965.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000173867.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000174171.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000175061.13 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000175147.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000175701.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000175701.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000175773.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000177337.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000177410.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000177640.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000177738.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000177738.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000177853.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000177993.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000178412.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000178440.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000179818.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000180458.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000180846.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000181798.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000182021.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000182109.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000182873.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000184068.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000185044.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000185203.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000186019.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000186594.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000186594.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000186842.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000187229.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000187621.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000187621.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000189149.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000189149.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000189223.9 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000189419.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000196553.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000196559.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000196559.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000196951.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000196972.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000197291.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000197308.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000197332.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000197332.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000197670.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000198221.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000203288.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000203362.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000203362.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000203441.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000203706.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000203721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000203739.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000203999.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000204054.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000204272.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000204362.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000204623.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000204791.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000204802.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000204837.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000204934.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000205266.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000205488.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000205662.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000205663.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000205959.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000206028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000206195.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000206195.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000206573.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000212694.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000214049.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000214407.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000214559.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000214725.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000214770.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000214837.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000214922.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000215068.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000215159.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000215394.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000215424.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000215863.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000215866.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000215869.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000217576.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000221817.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000222041.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000222041.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000223356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000223374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223380.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000223380.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000223382.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223382.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000223477.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000223478.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223692.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000223725.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000223745.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223749.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223764.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000223779.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000223797.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000223804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000223884.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000223907.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000223911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000223960.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224032.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224043.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000224078.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224116.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000224358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224468.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224490.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224505.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224621.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000224635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224687.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224687.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000224699.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224713.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224729.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224738.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000224790.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000224821.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224844.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224846.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000224848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000224897.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000224905.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000224914.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224930.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000224934.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000224959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000224992.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000225039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000225177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225210.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000225255.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225278.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225376.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225439.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225439.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000225465.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000225684.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000225703.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000225760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000225762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225767.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225783.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000225916.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225930.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225963.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000225981.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000226007.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226009.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226029.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226089.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000226115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226200.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226287.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226291.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000226312.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000226328.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000226332.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000226334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000226335.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000226352.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226380.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226380.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000226381.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226419.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000226445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000226471.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226648.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000226688.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226696.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226746.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226772.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226852.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226869.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000226877.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226889.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000226920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000226920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000227036.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227053.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000227110.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000227136.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000227193.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227200.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000227245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227354.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227372.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000227372.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000227388.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000227496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000227518.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227527.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000227540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227543.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227617.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000227627.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227673.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227740.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000227741.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227857.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000227896.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000227906.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000227959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228016.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228022.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000228022.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228115.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000228124.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000228126.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228204.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000228214.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228288.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228294.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228302.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228302.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000228315.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228372.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228506.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228544.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228544.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000228554.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000228604.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228614.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000228629.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228629.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000228630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228649.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228661.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000228682.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000228763.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000228838.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000228838.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000228839.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000228952.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229021.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000229118.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000229124.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229373.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229512.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229558.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000229587.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000229656.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229656.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000229728.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229750.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000229780.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000229852.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229852.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229874.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000229955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229956.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000229999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230002.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000230015.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230021.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230046.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000230082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000230084.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000230124.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230212.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000230303.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230337.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230337.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000230366.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230438.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230470.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000230479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000230499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230506.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230530.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000230552.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230555.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000230565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230606.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000230612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230633.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000230641.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230648.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230699.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230699.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230850.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000230912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231010.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000231010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231073.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000231074.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231079.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231113.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000231154.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231154.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000231160.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231242.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231294.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231305.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231312.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231407.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000231439.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231473.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231512.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231518.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231528.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231607.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000231612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231616.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231711.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000231711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231731.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231851.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000231856.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000231889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231948.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000231976.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000231993.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000232046.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000232116.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232151.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000232300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000232470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232480.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232480.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000232487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000232519.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000232533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000232586.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000232593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000232613.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232640.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232656.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000232677.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232677.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000232710.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232710.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000232719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232725.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232759.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000232762.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000232814.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232907.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000232909.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000232956.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000233044.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233056.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000233077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000233154.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233178.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233203.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233223.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233223.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000233237.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000233244.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000233334.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000233368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233396.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233429.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233461.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000233515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233547.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000233547.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000233554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233554.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000233559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000233621.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233718.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233757.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233757.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000233766.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000233791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233817.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000233845.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000233864.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000233901.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000233937.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234006.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000234019.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000234028.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234076.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000234134.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234147.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234160.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234185.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000234191.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000234255.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234263.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000234264.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234281.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234292.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000234378.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000234380.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000234393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234449.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234503.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000234535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000234616.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000234617.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000234630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234684.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234690.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234722.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234771.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234779.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234793.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234817.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000234832.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000234880.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000234883.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000234936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234944.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000234996.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235027.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000235072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235100.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000235244.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235296.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235314.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235398.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235423.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000235461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000235477.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235481.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235530.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235560.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235560.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000235586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000235663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235703.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000235706.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000235760.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235781.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000235802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235806.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000235843.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000235852.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235884.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235903.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235910.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000235919.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235927.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235927.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000235947.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000235954.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000235999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236064.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236088.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236098.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236144.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236194.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236199.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000236255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236256.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236269.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000236308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000236318.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236364.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236404.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236432.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236438.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236451.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236463.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236526.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000236537.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000236545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236581.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236671.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236778.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236824.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000236830.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236842.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000236859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236861.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236861.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236869.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000236901.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236901.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000236908.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000236914.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236943.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000236943.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000236947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000237037.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237037.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000237159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237200.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237200.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000237301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000237410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237436.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000237457.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000237481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000237491.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000237502.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000237523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000237543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000237588.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237594.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237781.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000237813.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000237819.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000237819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000237836.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000237862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000237883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000237938.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000237940.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000237976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000237989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000237998.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000237998.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000238005.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000238005.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000238018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000238058.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000238113.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000238141.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000238186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000238186.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000238198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000238246.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000238279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000238287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000239335.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000239353.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000239415.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000239480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000239593.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000239705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000239801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000240032.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000240137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000240288.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000240350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000240440.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000240449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000240476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000240618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000240758.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000240996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000241054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000241180.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000241313.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000241316.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000241481.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000241505.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000241769.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000241886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000241933.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000242082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000242125.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000242125.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000242154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000242282.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000242288.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000242396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000242474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000242512.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000242516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000242553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000242569.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000242622.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000242759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000242791.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000242791.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000243055.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000243107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000243243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000243350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000243415.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000243433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000243485.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000243533.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000243701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000243810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000243836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000243902.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000243926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000243926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000244128.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000244161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000244300.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000244300.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000244306.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000244306.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000244332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000244393.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000244459.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000244479.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000244578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000244625.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000244649.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000244879.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000244968.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000244998.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000245105.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000245322.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000245466.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000245498.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000245522.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000245526.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000245534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000245552.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000245571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000245685.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000245729.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000245748.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000245849.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000245910.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000245937.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000245975.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246090.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246095.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000246174.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000246225.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246250.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000246263.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000246323.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000246339.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246379.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246465.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000246523.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246528.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246560.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246640.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246731.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246792.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000246859.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000246889.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000246898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000246985.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247134.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000247199.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247311.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247311.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000247324.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247373.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247400.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247416.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247572.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247708.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247877.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000247950.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000248079.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248100.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000248223.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000248240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248256.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248367.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248508.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248559.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000248576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000248724.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000248734.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000248771.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000248774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000248810.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000248932.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000248932.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000249042.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000249234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000249249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000249348.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000249375.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000249423.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000249494.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000249592.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000249602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000249635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000249655.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000249685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000249740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000249740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000249846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000249870.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250027.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000250039.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250116.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250132.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250303.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000250320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250365.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250366.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000250397.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000250508.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000250616.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250659.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000250699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000250765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250765.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000250802.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250802.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000250842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000250910.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250950.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000250986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000250999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251003.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251009.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000251131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000251136.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000251136.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000251161.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251164.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000251175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000251175.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000251175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251221.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000251259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000251307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000251323.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000251359.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000251523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000251555.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000251666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000251666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000253106.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253121.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000253194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000253227.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253352.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000253392.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000253395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253408.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253490.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000253509.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253552.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253567.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000253616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253696.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253754.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000253773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000253844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000253854.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000253865.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253878.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000253961.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000253982.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000253986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254099.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000254154.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254266.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254333.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254389.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254631.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000254639.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254691.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000254814.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254855.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000254898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000254964.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000254966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255026.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000255100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255139.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255139.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000255160.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000255197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000255198.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255326.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255337.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000255434.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255449.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000255458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255471.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000255557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255723.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000255843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000255933.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000255966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000256116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000256196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000256250.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000256250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000256278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000256360.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000256360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000256712.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000256712.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000256747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000256802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000256967.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000256984.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000257023.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000257151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000257176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000257221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000257261.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000257270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000257496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000257534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000257556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000257563.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000257605.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000257647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000257660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000257671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000257815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000257817.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000257913.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000257964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258122.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000258136.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000258199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258301.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258302.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000258344.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258354.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000258441.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258450.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000258515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258525.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258525.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000258534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000258545.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000258603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000258633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000258642.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000258658.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000258682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258748.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258748.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000258789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258919.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258920.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000258940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000258955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000258957.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000258957.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000258976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259001.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259062.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259062.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000259065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000259118.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000259146.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259206.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259242.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259264.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259354.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259416.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259417.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259426.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259448.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259553.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259606.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259656.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259673.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259715.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259727.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259767.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000259772.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259793.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000259877.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000259994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260032.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000260046.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260060.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260132.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000260156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260163.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260209.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000260219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260233.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260269.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000260276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260277.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260296.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260328.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260352.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260361.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260381.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260400.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260404.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260411.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260425.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260536.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000260572.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260581.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000260583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260591.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000260597.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260608.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260626.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260650.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260660.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000260671.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260708.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260743.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260751.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260766.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000260790.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000260804.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260830.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000260830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260837.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260838.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260858.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000260871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260877.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260891.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000260891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000260896.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260910.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260919.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000260923.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000260936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000260938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000260942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260942.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000260947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260949.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000260953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000260973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261000.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000261002.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000261005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261005.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000261024.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261051.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261064.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000261105.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000261124.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261168.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261200.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261207.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000261216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261220.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000261251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261267.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000261288.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261295.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000261329.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000261341.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261428.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000261468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000261469.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000261474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000261496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261512.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000261513.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261560.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000261570.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000261596.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261597.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261600.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000261613.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261632.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000261662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000261663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000261712.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000261731.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261775.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261879.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261916.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261924.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000261925.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000261971.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000262152.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000262165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262434.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000262580.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262652.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262686.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000262703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262837.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262848.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000262873.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000262879.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000262951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263080.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000263220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263272.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263350.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000263412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000263470.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000263531.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263680.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263731.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263847.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263859.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000263884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000263934.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000263938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000263975.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000264107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000264112.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000264167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264247.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264304.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264491.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264608.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264608.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000264673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000264729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000264769.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264860.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000264932.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000264932.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000264937.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000265206.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000265218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000265242.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000265443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000265692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000265749.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000265791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000265800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000265800.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000265845.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000265888.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000266040.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266313.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266340.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000266401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000266445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000266538.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000266601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000266651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000266667.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000266709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000266895.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000266897.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000266903.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266916.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266918.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000266969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000266969.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000267002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267040.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267053.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267150.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000267152.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267211.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267212.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000267213.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267246.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267248.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000267249.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000267280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267296.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267348.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000267419.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000267470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267498.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000267581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267715.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267750.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000267758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267767.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267778.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267778.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267868.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000267871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000267886.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000267934.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268157.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268262.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268471.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268549.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000268573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268573.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000268583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268584.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268683.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268743.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000268746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268812.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268889.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000268912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000268938.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000269038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269054.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269086.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269091.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269191.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269202.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269293.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000269356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269376.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269386.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269392.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000269425.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269481.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000269489.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269489.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269560.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269640.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000269680.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269694.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269792.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269806.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000269814.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269836.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000269893.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269896.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269900.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269921.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269923.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000269927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269961.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000269966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269971.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000269972.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000269987.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000269999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000270000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000270010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270012.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270012.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000270018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270022.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000270035.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270041.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270060.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000270061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270062.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000270062.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000270066.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000270069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000270081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000270084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270104.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000270109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270116.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000270130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270171.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270189.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000270190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000270195.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000270210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270223.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270246.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270344.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270346.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000270361.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000270462.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270487.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270681.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270704.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000270964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271009.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000271020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271147.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271200.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000271265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271324.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271359.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000271382.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000271387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271398.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271398.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000271430.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000271551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271554.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000271579.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271590.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271631.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271659.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271778.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000271789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271815.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000271826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271889.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271963.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271971.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000271993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000271998.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272003.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272004.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000272004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272070.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000272076.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000272077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272077.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000272087.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272103.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000272103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272112.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000272121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000272137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272146.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272172.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000272192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272198.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000272205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272225.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272240.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000272248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272301.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272338.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272374.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000272375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272430.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272438.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000272440.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272452.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272472.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272508.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000272524.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272549.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000272562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272574.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272662.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272667.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272707.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272720.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000272755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272769.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000272777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272788.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272792.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272810.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Dasatinib |
ENSG00000272812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272812.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000272815.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000272828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272846.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272849.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272861.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Dasatinib |
ENSG00000272864.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000272872.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272902.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000272977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272989.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000272995.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273000.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273008.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273026.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273066.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273076.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000273091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273102.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273108.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Dasatinib |
ENSG00000273148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273156.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273247.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273309.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Dasatinib |
ENSG00000273311.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273321.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273353.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273369.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273402.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273437.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Dasatinib |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
ENSG00000273486.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Dasatinib |
hsa-miR-101-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-106a-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-130a-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-142-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-146b-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-153-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-17-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-181d |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-183-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-18a-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-18b-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-19a-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-19b-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-200a-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-200b-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-20a-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-20b-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-219a-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-22-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-24-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-27b-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-30a-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-30c-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-34a-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-375 |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-425-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-454-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-7-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-92a-3p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-93-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
hsa-miR-99b-5p |
predicted miRNA |
NCI60 |
|
| Dasatinib |
miR-17 |
Curated miRNA |
chronic myeloid leukemia |
|
| Dasatinib |
miR-217 |
Curated miRNA |
leukemia |
|
| Dasatinib |
miR-3127 |
Curated miRNA |
non-small cell lung cancer |
|
